BioSpace News Archive

Press Releases

MindMaze Therapeutics and Vibra Healthcare Announce Breakthrough RWE Results in High-Dose, High-Intensity Neurorehabilitation

March 31, 2026
·
5 min read
Press Releases

Abbisko Therapeutics’ FGFR2/3 Inhibitor ABSK061 Receives FDA IND Clearance for Achondroplasia in Children

March 31, 2026
·
2 min read
Press Releases

Avacta announces first patient treated in Phase 1 FOCUS-01 trial of FAP-Exd (AVA6103) - a sustained-release pre|CISION® exatecan peptide drug conjugate

March 31, 2026
·
5 min read
Press Releases

EURneffy 1 mg approved across the EU as the first and only needle-free adrenaline treatment for young children (≥15 kg) at risk of anaphylaxis

March 31, 2026
·
3 min read
Press Releases

CancerVax Reports Successful Initial Mouse Study with Breakthrough Results

March 31, 2026
·
6 min read
Press Releases

MaaT Pharma Announces 2025 Annual Results and Provides Business Updates

March 31, 2026
·
17 min read
Press Releases

Oculis Announces European Medicines Agency PRIME Designation for Privosegtor, Advancing a Potential First‑in‑Class Neuroprotective Candidate for Optic Neuritis

March 31, 2026
·
9 min read
Press Releases

Innocan Pharma Reports 2025 Financial Results, with Revenues at US $26.6M

March 31, 2026
·
6 min read
Press Releases

LENSAR® Reports Fourth Quarter and Full Year 2025 Results and Provides Business Update

March 31, 2026
·
17 min read
Press Releases

Alfasigma Reports Solid Performance in 2025 Supported by Double-Digit Revenue Growth in key strategic brands in Immunology (+17%1), Gastroenterology (+15%), Vascular (+10%), and Consumer Healthcare expansion portfolio in international markets

March 31, 2026
·
5 min read